>北美脂质 POCT 市场，按类型（仪器、耗材和试剂盒）、应用（高脂血症、高甘油三酯血症、高脂蛋白血症、家族性高胆固醇血症、丹吉尔病等）、模式（处方检测、OTC 检测）、品牌（Roche Reflotron、Roche Cobas B 101、Alere Cholestech LDX、Alere Afinion、Samsung Labgeo、PTS Cardiochek 等）、平台（横向流动测定（免疫层析测试）、分子诊断、免疫测定、试纸、微流体）、最终用户（医院、专业诊断中心、家庭护理、研究实验室、其他最终用户）、分销渠道（直接招标、零售）、国家（美国、加拿大和墨西哥）行业趋势和预测到 2028 年
市场分析和洞察：北美脂质 POCT 市场
预计脂质 POCT 市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，该市场的复合年增长率为 4.9%，预计到 2028 年将达到 4.572 亿美元。慢性感染数量的增加导致人们选择即时检测试剂盒和产品进行检测，因此这将推动脂质 POCT 市场的增长。
POCT 的特点是可以在患者附近进行检测，可以立即做出医疗决策，包括结果和监测。脂质 POCT 也称为患者脂质检测，它允许医生在几分钟内（而不是几小时内）准确测量实时、实验室质量的诊断结果。
新的生物技术进步创造了巨大的推动因素，推动了脂质 POCT 市场的增长。产品成本高可能会阻碍脂质 POCT 市场的增长。医疗保健支出的增加有望为脂质 POCT 市场的增长提供机会。实验室测试结果不一致给脂质 POCT 市场带来了巨大挑战。
脂质 POCT 市场报告提供了市场份额、新发展和产品线分析、国内和本地市场参与者的影响的详细信息，分析了新兴收入领域、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新方面的机会。要了解分析和脂质 POCT 市场情景，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您创建收入影响解决方案以实现您的预期目标。
脂质 POCT 市场范围和市场规模
脂质 POCT 市场根据类型、应用、模式、品牌、平台、最终用户和分销渠道分为七个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据类型，脂质 POCT 市场细分为仪器、耗材和试剂盒。2021 年，由于生活方式的改变和慢性病的增加以及对非处方 POCT 设备的认识不足，脂质 POCT 市场中的仪器部分预计将增长。
- 根据应用，脂质 POCT 市场细分为高脂血症、高甘油三酯血症、高脂蛋白血症、丹吉尔病、家族性高胆固醇血症等。2021 年，由于老年人口增加和不健康的生活方式，脂质 POCT 市场中的高脂血症细分市场预计将占据主导地位。
- 根据模式，脂质 POCT 市场分为非处方检测和处方检测。2021 年，脂质 POCT 市场中的处方检测部分预计将占据主导地位，因为医院和熟练的实验室专业人员高度推荐使用即时脂质检测进行脂质分析。
- 根据品牌，脂质 POCT 市场细分为罗氏 reflotron、罗氏 cobas B 101、alere cholestech LDX、alere afinion、三星 labgeo、PTS cardiochek 等。2021 年，罗氏 reflectron 部门预计将在脂质 POCT 市场占据主导地位，因为它们的技术比即时诊断设备更先进。
- 根据平台，脂质 POCT 市场细分为横向流动检测（免疫层析检测）、试纸、微流体、分子诊断和免疫检测。2021 年，脂质 POCT 市场中的横向流动检测（免疫层析检测）部分预计将因先进技术和发明而增长。
- 根据最终用户，脂质 POCT 市场细分为医院、专业诊断中心、家庭护理、研究实验室和其他最终用户。2021 年，由于患者对诊断操作的重视程度不断提高，脂质 POCT 市场中的医院部分预计将增长。
- 根据分销渠道，脂质 POCT 市场分为直接招标和零售。2021 年，脂质 POCT 市场的直接招标部分预计将增长，因为对先进技术的需求以及手术和诊断医疗保健的测试要求增加。
脂质 POCT 市场国家/地区分析
对脂质 POCT 市场进行分析，并按上述国家、类型、应用、模式、品牌、平台、最终用户和分销渠道提供市场规模信息。
北美脂质 POCT 市场覆盖的国家包括美国、加拿大和墨西哥。
由于慢性病发病率不断上升和技术进步，美国在市场上占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少的竞争而面临的挑战、销售渠道的影响。
制造商推出的新产品为脂质 POCT 市场参与者创造了新的机会
脂质 POCT 市场还为您提供了每个国家/地区美容行业增长的详细市场分析，包括脂质 POCT 市场销售、脂质 POCT 市场发展的影响以及监管环境的变化及其对脂质 POCT 市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和脂质 POCT 市场份额分析
脂质 POCT 市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对脂质 POCT 市场的关注有关。
北美脂质 POCT 市场的主要脂质 POCT 产品供应商包括 Abbott、F.Hoffmann-La Roche Ltd.、Nova Biomedical、Calligari Srl、AMD SOLUTIONS、EuroMedix、Siemens Healthcare GmbH（西门子的子公司）、Jant Pharmacal Corporation、Samsung Medison Co., Ltd.、A. Menarini Diagnostics srl、ACON Laboratories, Inc.、PRIMA Lab SA、Quest Diagnostics Incorporated 和 SKYLA CORPORATION 等国内公司。DBMR 分析师了解竞争优势，并为每个竞争对手分别提供竞争分析。
全球各地的许多公司也推出了许多产品并签署了多项协议，这也加速了脂质 POCT 市场的发展。
例如，
- 2020 年 11 月，SD Biosensor, INC. 宣布与 DKSH Korea 合作，共同发展药房血糖业务。这将有助于该公司在未来几年实现市场多元化。
市场参与者的合作、合资和其他策略正在增强公司在脂质 POCT 市场中的市场，这也为组织改善其在脂质 POCT 市场中的产品提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA LIPID POCT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 DISTRIBUTION CHANNEL LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES
5.1.2 IMPROVING DIAGNOSIS SEEKING RATE
5.1.3 RISING TECHNOLOGICAL ADVANCEMENTS
5.1.4 RISING GERIATRIC POPULATION ACROSS THE GLOBE
5.1.5 RISING PREFERENCE FOR HOMECARE TESTING
5.2 RESTRAINTS
5.2.1 PRODUCT RECALLS
5.2.2 HIGH COSTS OF PRODUCTS
5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
5.3.2 RISING HEALTHCARE EXPENDITURE
5.3.3 PANDEMIC OUTBREAK OF COVID-19
5.3.4 GROWING DEMAND FOR BETTER QUALITY HEALTHCARE AND EARLY DIAGNOSIS
5.4 CHALLENGES
5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES
5.4.2 LACK OF ACCESSIBILITY
6 IMPACT OF COVID-19 ON THE NORTH AMERICA LIPID POCT MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19
6.5 CONCLUSION:
1 NORTH AMERICA LIPID POCT MARKET, BY TYPE
1.1 OVERVIEW
1.2 INSTRUMENTS
1.2.1 ANALYZERS
1.2.1.1 PORTABLE
1.2.1.2 HANDHELD
1.2.1.3 STANDALONE
1.2.2 METER
1.2.3 BLOOD MONITORING DEVICE
1.2.4 OTHER POC PRODUCTS
1.3 CONSUMABLES AND KITS
1.3.1 CHOLESTEROL TEST KITS
1.3.2 STRIPS
1.3.3 ACCESSORIES
1.3.4 OTHERS
2 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION
2.1 OVERVIEW
2.2 HYPERLIPIDEMIA
2.3 HYPERTRIGLYCERIDEMIA
2.4 HYPERLIPOPROTEINEMIA
2.5 FAMILIAL HYPERCHOLESTEROLEMIA
2.6 TANGIER DISEASE
2.7 OTHERS
3 NORTH AMERICA LIPID POCT MARKET, BY MODE
3.1 OVERVIEW
3.2 PRESCRIPTION-BASED TESTING
3.3 OTC-BASED TESTING
4 NORTH AMERICA LIPID POCT MARKET, BY BRAND
4.1 OVERVIEW
4.2 ROCHE REFLOTRON
4.3 ROCHE COBAS B 101
4.4 ALERE CHOLESTECH LDX
4.5 ALERE AFINION
4.6 PTS CARDIOCHEK
4.7 OTHERS
5 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM
5.1 OVERVIEW
5.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS
5.3 MOLECULAR DIAGNOSTICS
5.4 IMMUNOASSAYS
5.5 DIPSTICKS
5.6 MICROFLUIDICS
6 NORTH AMERICA LIPID POCT MARKET, BY END USER
6.1 OVERVIEW
6.2 HOSPITALS
6.3 PROFESSIONAL DIAGNOSTIC CENTERS
6.3.1 CLINICAL LABORATORIES
6.3.2 OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS
6.4 HOME CARE
6.5 RESEARCH LABORATORIES
6.6 OTHER END USERS
7 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL
7.1 OVERVIEW
7.2 DIRECT TENDERS
7.3 RETAIL SALES
8 NORTH AMERICA LIPID POCT MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 U.S.
8.1.2 CANADA
8.1.3 MEXICO
9 NORTH AMERICA LIPID POCT MARKET: COMPANY LANDSCAPE
9.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
10 SWOT ANALYSIS
11 COMPANY PROFILES
11.1 F. HOFFMANN-LA ROCHE LTD
11.1.1 COMPANY SNAPSHOT
11.1.2 REVENUE ANALYSIS
11.1.3 COMPANY SHARE ANALYSIS
11.1.4 PRODUCT PORTFOLIO
11.1.5 RECENT DEVELOPMENT
11.2 ABBOTT
11.2.1 COMPANY SNAPSHOT
11.2.2 REVENUE ANALYSIS
11.2.3 COMPANY SHARE ANALYSIS
11.2.4 PRODUCT PORTFOLIO
11.2.5 RECENT DEVELOPMENT
11.3 SIEMENS HEALTHCARE GMBH (A SUBSIDIARY OF SIEMENS)
11.3.1 COMPANY SNAPSHOT
11.3.2 REVENUE ANALYSIS
11.3.3 COMPANY SHARE ANALYSIS
11.3.4 PRODUCT PORTFOLIO
11.3.5 RECENT DEVELOPMENTS
11.4 QUEST DIAGNOSTICS INCORPORATED
11.4.1 COMPANY SNAPSHOT
11.4.2 REVENUE ANALYSIS
11.4.3 COMPANY SHARE ANALYSIS
11.4.4 PRODUCT PORTFOLIO
11.4.5 RECENT DEVELOPMENTS
11.5 A. MENARINI DIAGNOSTICS S.R.L
11.5.1 COMPANY SNAPSHOT
11.5.2 COMPANY SHARE ANALYSIS
11.5.3 PRODUCT PORTFOLIO
11.5.4 RECENT DEVELOPMENT
11.6 ACON LABORATORIES, INC.
11.6.1 COMPANY SNAPSHOT
11.6.2 PRODUCT PORTFOLIO
11.6.3 RECENT DEVELOPMENT
11.7 AMD SOLUTIONS
11.7.1 COMPANY SNAPSHOT
11.7.2 PRODUCT PORTFOLIO
11.7.3 RECENT DEVELOPMENTS
11.8 CALLEGARI SRL
11.8.1 COMPANY SNAPSHOT
11.8.2 PRODUCT PORTFOLIO
11.8.3 RECENT DEVELOPMENTS
11.9 EUROMEDIX
11.9.1 COMPANY SNAPSHOT
11.9.2 PRODUCT PORTFOLIO
11.9.3 RECENT DEVELOPMENT
11.1 GENERAL LIFE BIOTECHNOLOGY CO., LTD.
11.10.1 COMPANY SNAPSHOT
11.10.2 PRODUCT PORTFOLIO
11.10.3 RECENT DEVELOPMENTS
11.11 JANT PHARMACAL CORPORATION
11.11.1 COMPANY SNAPSHOT
11.11.2 PRODUCT PORTFOLIO
11.11.3 RECENT DEVELOPMENT
11.12 MICO BIOMED
11.12.1 COMPANY SNAPSHOT
11.12.2 PRODUCT PORTFOLIO
11.12.3 RECENT DEVELOPMENTS
11.13 NOVA BIOMEDICAL
11.13.1 COMPANY SNAPSHOT
11.13.2 PRODUCT PORTFOLIO
11.13.3 RECENT DEVELOPMENTS
11.14 PRIMA LAB SA
11.14.1 COMPANY SNAPSHOT
11.14.2 PRODUCT PORTFOLIO
11.14.3 RECENT DEVELOPMENTS
11.15 PTS DIAGNOSTICS
11.15.1 COMPANY SNAPSHOT
11.15.2 PRODUCT PORTFOLIO
11.15.3 RECENT DEVELOPMENTS
11.16 SD BIOSENSOR, INC.
11.16.1 COMPANY SNAPSHOT
11.16.2 PRODUCT PORTFOLIO
11.16.3 RECENT DEVELOPMENTS
11.17 SKYLA CORPORATION
11.17.1 COMPANY SNAPSHOT
11.17.2 PRODUCT PORTFOLIO
11.17.3 RECENT DEVELOPMENTS
11.18 TASCOM
11.18.1 COMPANY SNAPSHOT
11.18.2 PRODUCT PORTFOLIO
11.18.3 RECENT DEVELOPMENT
11.19 TRINITY BIOTECH
11.19.1 COMPANY SNAPSHOT
11.19.2 REVENUE ANALYSIS
11.19.3 PRODUCT PORTFOLIO
11.19.4 RECENT DEVELOPMENTS
11.2 SAMSUNG MEDISON CO., LTD.
11.20.1 COMPANY SNAPSHOT
11.20.2 PRODUCT PORTFOLIO
11.20.3 RECENT DEVELOPMENT
12 QUESTIONNAIRE
13 RELATED REPORTS
表格列表
LIST OF TABLES
TABLE 1 BELOW MENTIONED TABLE SHOWS THE COST OF VARIOUS LIPID POCT DEVICES OFFERED BY DIFFERENT MANUFACTURERS:
TABLE 1 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 2 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 4 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 5 NORTH AMERICA CONSUMABLES & KITS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE , 2019-2028 (USD MILLION)
TABLE 7 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 8 NORTH AMERICA HYPERLIPIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 NORTH AMERICA HYPERTRIGLYCERIDEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 NORTH AMERICA HYPERLIPOPROTEINEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 NORTH AMERICA FAMILIAL HYPERCHOLESTEROLEMIA IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 NORTH AMERICA TANGIER DISEASE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019 – 2028, (USD MILLION)
TABLE 15 NORTH AMERICA PRESCRIPTION-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 NORTH AMERICA OTC-BASED TESTING IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 18 NORTH AMERICA ROCHE REFLOTRON IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 NORTH AMERICA ROCHE COBAS B 101 IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 NORTH AMERICA ALERE CHOLESTECH LDX IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 NORTH AMERICA ALERE AFINION IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 NORTH AMERICA PTS CARDIOCHEK IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 NORTH AMERICA OTHERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 25 NORTH AMERICA LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 NORTH AMERICA IMMUNOASSAYS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 NORTH AMERICA DIPSTICKS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 NORTH AMERICA MICROFLUIDICS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 NORTH AMERICA HOSPITALS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 34 NORTH AMERICA HOME CARE IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 NORTH AMERICA RESEARCH LABORATORIES IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 NORTH AMERICA OTHER END USERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 38 NORTH AMERICA DIRECT TENDERS IN LIPID POCT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 NORTH AMERICA RETAIL SALES IN LIPID POCT MARKET, BY REGION 2019-2028 (USD MILLION)
TABLE 40 NORTH AMERICA LIPID POCT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 41 NORTH AMERICA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 42 NORTH AMERICA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 43 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 44 NORTH AMERICA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 45 NORTH AMERICA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 NORTH AMERICA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 NORTH AMERICA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 48 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 49 NORTH AMERICA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 50 NORTH AMERICA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 51 NORTH AMERICA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 52 NORTH AMERICA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 53 NORTH AMERICA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 54 U.S. LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 U.S. INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 U.S. ANALYZERS IN LIPID POCT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 57 U.S. ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 58 U.S. CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 U.S. LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 60 U.S. LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 61 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 62 U.S. LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 63 U.S. LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 64 U.S. LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 65 U.S. PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 66 U.S. LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 67 CANADA LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 CANADA INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 CANADA ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 70 CANADA ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 71 CANADA CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 72 CANADA LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 73 CANADA LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 74 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 75 CANADA LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 76 CANADA LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 77 CANADA LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 CANADA PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 79 CANADA LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 MEXICO LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 81 MEXICO INSTRUMENTS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 MEXICO ANALYZERS IN POINT OF CARE TESTING MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 83 MEXICO ANALYZERS IN LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 84 MEXICO CONSUMABLES AND KITS IN LIPID POCT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 85 MEXICO LIPID POCT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 MEXICO LIPID POCT MARKET, BY MODE, 2019-2028 (USD MILLION)
TABLE 87 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (USD MILLION)
TABLE 88 MEXICO LIPID POCT MARKET, BY BRAND, 2019-2028 (UNITS)
TABLE 89 MEXICO LIPID POCT MARKET, BY PLATFORM, 2019-2028 (USD MILLION)
TABLE 90 MEXICO LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 91 MEXICO PROFESSIONAL DIAGNOSTIC CENTERS IN LIPID POCT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 92 MEXICO LIPID POCT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
图片列表
LIST OF FIGURES
FIGURE 1 NORTH AMERICA LIPID POCT MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA LIPID POCT MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA LIPID POCT MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA LIPID POCT MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA LIPID POCT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA LIPID POCT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA LIPID POCT MARKET: MULTIVARIATE MODELLING
FIGURE 8 NORTH AMERICA LIPID POCT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA LIPID POCT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA LIPID POCT MARKET: SEGMENTATION
FIGURE 11 INCREASING PREVALENCE OF CHRONIC DISEASE AND IMPROVING DIAGNOSIS SEEKING RATE ARE EXPECTED TO DRIVE THE NORTH AMERICA LIPID POCT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSTRUMENTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA LIPID POCT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF NORTH AMERICA LIPID POCT MARKET
FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT
FIGURE 15 MEDICAL DEVICE SPENDING VS. NATIONAL HEALTH EXPENDITURES IN 2016
FIGURE 1 NORTH AMERICA LIPID POCT MARKET: BY TYPE, 2020
FIGURE 2 NORTH AMERICA LIPID POCT MARKET: BY TYPE, 2019-2028 (USD MILLION)
FIGURE 3 NORTH AMERICA LIPID POCT MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 4 NORTH AMERICA LIPID POCT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 5 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, 2020
FIGURE 6 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, 2019-2028 (USD MILLION)
FIGURE 7 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 8 NORTH AMERICA LIPID POCT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 9 NORTH AMERICA LIPID POCT MARKET: BY MODE, 2020
FIGURE 10 NORTH AMERICA LIPID POCT MARKET: BY MODE, 2019-2028 (USD MILLION)
FIGURE 11 NORTH AMERICA LIPID POCT MARKET: BY MODE, CAGR (2021-2028)
FIGURE 12 NORTH AMERICA LIPID POCT MARKET: BY MODE, LIFELINE CURVE
FIGURE 13 NORTH AMERICA LIPID POCT MARKET: BY BRAND, 2020
FIGURE 14 NORTH AMERICA LIPID POCT MARKET: BY BRAND, 2020-2028 (USD MILLION)
FIGURE 15 NORTH AMERICA LIPID POCT MARKET: BY BRAND, CAGR (2021-2028)
FIGURE 16 NORTH AMERICA LIPID POCT MARKET: BY BRAND, LIFELINE CURVE
FIGURE 17 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, 2020
FIGURE 18 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, 2019-2028 (USD MILLION)
FIGURE 19 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, CAGR (2021-2028)
FIGURE 20 NORTH AMERICA LIPID POCT MARKET: BY PLATFORM, LIFELINE CURVE
FIGURE 21 NORTH AMERICA LIPID POCT MARKET: BY END USER, 2020
FIGURE 22 NORTH AMERICA LIPID POCT MARKET: BY END USER, 2019-2028 (USD MILLION)
FIGURE 23 NORTH AMERICA LIPID POCT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 24 NORTH AMERICA LIPID POCT MARKET: BY END USER, LIFELINE CURVE
FIGURE 25 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 26 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
FIGURE 27 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 28 NORTH AMERICA LIPID POCT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 29 NORTH AMERICA LIPID POCT MARKET: SNAPSHOT (2020)
FIGURE 30 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2020)
FIGURE 31 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 32 NORTH AMERICA LIPID POCT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 33 NORTH AMERICA LIPID POCT MARKET: BY TYPE (2021-2028)
FIGURE 34 NORTH AMERICA LIPID POCT MARKET: COMPANY SHARE 2020 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
